Startups
Edit
https://efferon.com/
Systemic Inflammation Therapy Platform
TrustedLast activity: 10.11.2026
Active
Multimodal hemoadsorption technology for sepsis, septic shock, and cytokine release syndrome. CE-marked in the European Union.
Overview
Location
Germany
Total raised
$2.9M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 11, 2026 | Efferon is ‘selling time’ in the race to treat sepsis | Every minute one person in Europe dies from sepsis or septic shock. Sepsis arises when the body’s response to an infection injures its own tissues and organs. It may lead to shock, multi-organ failure, and death – especially if not recognis... |
| May 21, 2026 | Efferon secures €2.5M to grow blood purification platform | Biotech company Efferon has raised €2.5 million in a seed funding round led by private investors from the DACH region to support the European commercial expansion of Efferon LPS, its hemoadsorption device approved for the treatment of sepsi... |
| May 21, 2026 | Efferon Raises $2.9M in Seed Funding | |
| Efferon | “Efferon” |
Reviews 0
FAQ about Systemic Inflammation Therapy Platform
How much funding has Systemic Inflammation Therapy Platform raised?
Systemic Inflammation Therapy Platform has raised $2.9M in total across 1 funding round.
What has the press written about Systemic Inflammation Therapy Platform?
Parsers VC has collected 5 articles mentioning Systemic Inflammation Therapy Platform, among them “Efferon is ‘selling time’ in the race to treat sepsis” (Aug 11, 2026) and “Efferon secures €2.5M to grow blood purification platform” (May 21, 2026).
Is Systemic Inflammation Therapy Platform still active?
Yes, Systemic Inflammation Therapy Platform is active; its latest activity on Parsers VC dates from Nov 10, 2026.